GCG, glucagon, 2641

N. diseases: 441; N. variants: 10
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0948379
Disease: Impaired insulin secretion
Impaired insulin secretion
0.060 Biomarker disease BEFREE Diabetes is characterized by hyperglycemia due to impaired insulin secretion and aberrant glucagon secretion resulting from changes in pancreatic islet cell function and/or mass. 30805033 2019
CUI: C0948379
Disease: Impaired insulin secretion
Impaired insulin secretion
0.060 Biomarker disease BEFREE Their development emerged from the understanding that a combined islet dysfunction comprising of impaired insulin secretion and exaggerated glucagon secretion is the key defect of hyperglycemia. 30099845 2019
CUI: C0948379
Disease: Impaired insulin secretion
Impaired insulin secretion
0.060 Biomarker disease BEFREE GLP-1 analogue recovers impaired insulin secretion from human islets treated with palmitate via down-regulation of SOCS2. 27566229 2017
CUI: C0948379
Disease: Impaired insulin secretion
Impaired insulin secretion
0.060 Biomarker disease BEFREE Diabetes is characterized by hyperglycaemia due to impaired insulin secretion and aberrant glucagon secretion resulting from changes in pancreatic islet cell function and/or mass. 25145789 2014
CUI: C0948379
Disease: Impaired insulin secretion
Impaired insulin secretion
0.060 AlteredExpression disease BEFREE After glucagon stimulation, C-peptide levels rose from 0.46 nmol/l to 0.53 nmol/l, indicative of impaired insulin secretion. 9828917 1998
CUI: C0948379
Disease: Impaired insulin secretion
Impaired insulin secretion
0.060 Biomarker disease BEFREE Turner's syndrome and carbohydrate metabolism. I. Impaired insulin secretion after tolbutamide and glucagon stimulation tests: evidence of insulin deficiency. 463942 1979